10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
8.83
-0.34 (-3.66%)
Mar 31, 2025, 11:37 AM EDT - Market open

10x Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
1,0791,7386,6154,17116,64015,237
Upgrade
Market Cap Growth
-73.72%-73.72%58.59%-74.93%9.21%107.79%
Upgrade
Enterprise Value
7761,4266,3573,81516,12014,530
Upgrade
Last Close Price
9.1614.3655.9636.44148.96141.60
Upgrade
PS Ratio
1.812.8510.698.0833.9250.99
Upgrade
PB Ratio
1.582.458.935.1820.3520.62
Upgrade
P/TBV Ratio
2.522.529.195.3621.1321.26
Upgrade
P/OCF Ratio
163.15260.86----
Upgrade
EV/Sales Ratio
1.272.3410.277.3932.8648.62
Upgrade
Debt / Equity Ratio
0.120.120.130.120.100.09
Upgrade
Asset Turnover
0.650.650.620.500.500.39
Upgrade
Inventory Turnover
2.502.502.701.701.652.59
Upgrade
Quick Ratio
4.094.093.964.086.106.05
Upgrade
Current Ratio
4.974.974.694.856.776.56
Upgrade
Return on Equity (ROE)
-25.17%-25.17%-32.98%-20.45%-7.48%-93.64%
Upgrade
Return on Assets (ROA)
-12.77%-12.77%-12.52%-9.99%-3.40%-6.95%
Upgrade
Return on Capital (ROIC)
-14.77%-14.77%-14.37%-11.37%-3.89%-8.52%
Upgrade
Earnings Yield
-16.80%-10.51%-3.86%-3.98%-0.35%-3.56%
Upgrade
FCF Yield
-0.53%-0.33%-0.96%-3.96%-0.74%-1.67%
Upgrade
Buyback Yield / Dilution
-2.80%-2.80%-2.90%-3.18%-9.09%-158.76%
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q